Health Condition 1: C00-D49- Neoplasms
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
CIFAR Centre for Infertility and Assisted Reproduction
Eligibility
Inclusion criteria
Inclusion criteria: Cancer patient, all ages, all cancers, Newly diagnosed patients and have come for FP prior to exposure to potentially gonadotoxic treatment (eg chemotherapy, radiotherapy to gonads/pelvis) Relapsed cancer patients and have come for FP prior to exposure to potentially gonadotoxic treatment (eg chemotherapy, radiotherapy to gonads/pelvis) as part of relapse treatment but may have received gonadotoxic treatment during previous cancer treatment
Exclusion criteria
Exclusion criteria: Patients who refuse consent Patients who have already received gonadotoxic treatment as part of current cancer treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage patients who achieved FPTimepoint: After initial Assessment | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of male patients undergoing semen cryopreservation with good quality sperm motility samples - progressive motility more than 30 percent among those who achieved FPTimepoint: After initial assessment;Percentage of female patients undergoing embryo cryopreservation with Gardner Embryo Grading AA, AB, BB & BC among those who achieved FPTimepoint: After initial Assessment;Percentage of female patients undergoing oocyte cryopreservation with one or more metaphase II oocytes among those who achieved FPTimepoint: After initial Assessment;Percentage of male patients undergoing semen cryopreservation with good quality sperm count samples Males - Sperm count per ml more than 16 million per ml among those who achieved FPTimepoint: After initial Assessment | — |
Countries
India
Contacts
Public ContactPuneet Rana Arora
CIFAR Centre for Infertility and Assisted Reproduction
Outcome results
None listed